Jane Street
FBRX icon

Jane Street’s Forte Biosciences FBRX Stock Holding History

Jane Street’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-944
Closed -$51K – 10481
2021
Q4 		$51K Sell
944
-600
-39% -$40.4K ﹤0.01% 9527
2021
Q3 		$114K Buy
+1,544
New +$855K ﹤0.01% 9222

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Jane Street's FBRX Position: Q1 2026 in Review

Jane Street increased its Forte Biosciences (FBRX) stake by 594% in Q1 2026, buying an estimated $1.43M and bringing the position to 57,933 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #5643.

Jane Street first reported a position in FBRX in Q2 2020 and has held it in 6 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Jane Street held 57,933 shares of Forte Biosciences worth $1.5M as of Q1 2026.
  • Jane Street bought 49,589 Forte Biosciences shares in Q1 2026, an estimated $1.43M.
  • Forte Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5643 holding.
  • Jane Street first reported a position in Forte Biosciences in Q2 2020 and has held it in 6 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.